Genmab — Juni 2019

[Solsen]

ADCT-301 is looking very promising. Genmab own 25% and didnt use ops.in...

[kkjoel]

Nice tream, not? (Almost good cop -
bad cop)

[Sukkeralf]

And do we know what that 25% means - no cost but does that equal to 25% royalty?

[Bulder]

According to the homepage they own 25 % of the product rights. I assume that means no cost and 25 % royalty.

[troldmanden]

Det er ganske givet ikke 25% royalties men 25% af provenuet på stoffet. Så fra oms skal trækkes produktions salg og distributions udgifter. Så nok 15-19%

[Sukkeralf]

Jeg tror også mere noget i den retning - har spurgt Jan på en Q%A og der svarede han udenom. Måske fordi det ikke lige sådan er til at svare på.

[E_L]

from Nature Reviews Drug Discovery : Bispecific antibodies: a mechanistic review of the pipeline- https://www.nature.com/articles/s41573-019-0028-1
full article https://sci-hub.tw/https://www.nature.com/articles/s41573-019-0028-1

[E_L]

try full article again - https://sci-hub.tw/https://www.nature.com/articles/s41573-019-0028-1

[E_L]

(authors 2 genmab and 1 ex-genmab scientists)

[E_L]

In this video, Dr. Brian G.M. Durie provides details of the CASSIOPEIA trial. https://www.youtube.com/watch?v=NhuAkDVRAM4

[LyngeInv]

Alle kombinationer med dara viser jo game changing effects ...

[LyngeInv]

Nogle der har overblik over, hvor mange trials med dara vi venter resultater fra?

[Bulder]

Tættest på er vel Pleiaderne og Griffin. Dernæst Andromeda og senere Candor og Apollo.

[GeorgeBest]

og Asclepios i MS ofa

[Tandfeen-2]

Har I ca datoer?

[bibob]

God morgen.

[polle1]

God morgen og god dag

[Parasitism]

God morgen

[E_L]

another CASSIOPEIA inteview, with hillipe Moreau, MD - https://www.targetedonc.com/news/daratumumab-improves-responses-pfs-in-newly-diagnosed-transplanteligible-myeloma

[E_L]

"Moreau: I think that when we are going to use quadruplet combination including CD38 antibodies plus SCT, we are going to cure some young patients." I haven't heard anyone use the word 'cure' before...